Hasil Pencarian - Ricardo Restrepo-Jaramillo
- Menampilkan 1 - 7 hasil dari 7
-
1
-
2
Survival and drug persistence in patients receiving inhaled treprostinil at doses greater than 54 µg (nine breaths) four times daily oleh Shelley Shapiro, Stacy Mandras, Ricardo Restrepo‐Jaramillo, Eric Shen, Meredith Broderick, Youlan Rao, Dasom Lee, Andrew C. Nelsen
Diterbitkan 2021-10-01Dapatkan teks lengkap
Artikel -
3
A multicenter retrospective study of patients with pulmonary hypertension transitioned from inhaled to oral treprostinil oleh Diane L. Zwicke, Ricardo Restrepo-Jaramillo, Hassan Alnuaimat, Kathryn Gordon, Meredith Broderick, Lisa D. Edwards, Andrew Allmon, Peter J. Leary
Diterbitkan 2021-03-01Dapatkan teks lengkap
Artikel -
4
Differences in health policies for drug availability in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension across Latin America oleh Mauricio Orozco‐Levi, Jorge Cáneva, Caio Fernandes, Ricardo Restrepo‐Jaramillo, Nayeli Zayas, Rafael Conde, Mirta Diez, Carlos Jardim, Manuel C. Pacheco Gallego, Luciano Melatini, Héctor Valdéz, Tomás Pulido
Diterbitkan 2022-01-01Dapatkan teks lengkap
Artikel -
5
Safety of Macitentan for the Treatment of Portopulmonary Hypertension: Real-World Evidence from the Combined OPUS/OrPHeUS Studies oleh Nick H. Kim, Kelly M. Chin, Vallerie V. McLaughlin, Hilary DuBrock, Ricardo Restrepo-Jaramillo, Zeenat Safdar, Gwen MacDonald, Nicolas Martin, Daniel Rosenberg, Maria Solonets, Richard Channick
Diterbitkan 2024-01-01Dapatkan teks lengkap
Artikel -
6
BREEZE: Open‐label clinical study to evaluate the safety and tolerability of treprostinil inhalation powder as Tyvaso DPI™ in patients with pulmonary arterial hypertension oleh Leslie A. Spikes, Abubakr A. Bajwa, Charles D. Burger, Sapna V. Desai, Michael S. Eggert, Karim A. El‐Kersh, Micah R. Fisher, Shilpa Johri, Joanna M. Joly, Jinesh Mehta, Harold I. Palevsky, Gautam V. Ramani, Ricardo Restrepo‐Jaramillo, Sandeep Sahay, Trushil G. Shah, Chunqin Deng, Melissa Miceli, Peter Smith, Shelley M. Shapiro
Diterbitkan 2022-04-01Dapatkan teks lengkap
Artikel -
7
Delphi consensus recommendation for optimization of pulmonary hypertension therapy focusing on switching from a phosphodiesterase 5 inhibitor to riociguat oleh Franck F. Rahaghi, Vijay P. Balasubramanian, Robert C. Bourge, Charles D. Burger, Murali M. Chakinala, Michael S. Eggert, Jean M. Elwing, Jeremy Feldman, Christopher King, James R. Klinger, Stephen C. Mathai, John Wesley McConnell, Harold I. Palevsky, Ricardo Restrepo‐Jaramillo, Zeenat Safdar, Jeffrey S. Sager, Namita Sood, Roxana Sulica, R. James White, Nicholas S. Hill
Diterbitkan 2022-04-01Dapatkan teks lengkap
Artikel